Watchlist Price Alert

Contineum Therapeutics In... (CTNM)

NASDAQ: CTNM · Real-Time Price · USD

4.45

-0.18 (-3.89%)

At close: Jun 13, 2025, 3:59 PM

Contineum Therapeutics Class A Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-42.26M	22.72M	-24.25M	-29M
Depreciation & Amortization	258K	195K	329K	325K
Stock-Based Compensation	6.8M	2.22M	1.93M	1.75M
Other Working Capital	4.19M	-1.02M	-1.04M	218K
Other Non-Cash Items	-2.98M	-4.76M	5.96M	164K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	5.33M	-1.02M	-1.27M	108K
Operating Cash Flow	-32.84M	19.35M	-20.12M	-26.27M
Capital Expenditures	-514K	-414K	-118K	-168K
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-226.41M	-141.87M	-64.7M	-66.78M
Sales Maturities Of Investments	157.16M	76.71M	87.12M	1.98M
Other Investing Acitivies	20K	n/a	22.42M	-64.8M
Investing Cash Flow	-69.74M	-65.57M	22.3M	-64.97M
Debt Repayment	n/a	-3.75M	-1.25M	n/a
Common Stock Repurchased	n/a	-28K	-4K	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	790K	-184K	15K	113K
Financial Cash Flow	109M	56.18M	-1.24M	79.84M
Net Cash Flow	6.42M	9.96M	939K	-11.39M
Free Cash Flow	-33.36M	18.93M	-20.24M	-26.43M